Given that mutations in APC, KRAS, and BRAF are among the most frequently occurring genetic alterations in colorectal cancer, our findings suggest that the Prkci–c-Myc axis may represent a generalizable and mutation-independent oncogenic mechanism in CRC. Here, KRAS is linked to colorectal cancer.